“Just signed a new executive order for lower drug prices!” President wrote on Twitter. “My favorite nation order will ensure that our country gets the same low price that Big Pharma gives to other countries. The days of global freedom at the expense of America are over… ”
Pharmaceutical manufacturers vehemently opposed the executive order.
“The administration has chosen to pursue the most favored nation policy – an irresponsible and indescribable policy that will tell foreign governments how the US provides treatment and cure for senior citizens and those battling devastating diseases Is, “Stephen J. Ubl said, PhRMA’s chief executive, the industry’s largest business group.
“Worse,” he said, is that they are now expanding the policy to include drugs in both Medicare Part B and Part D, a belief that further jeopardizes America’s innovation leadership And threatens the use of drugs for tens of seniors. . “
BIO, the biotech industry trade group, was equally offended.
“With scientists and researchers from America’s biopharmaceutical companies working to fight the deadly epidemic of the clock, it is only dumb that the Trump administration move ahead with its threat to import foreign price controls and the inevitable for innovation Delay will follow, ”Dr. The group’s chief executive, Michelle McMary-Heath, said in a statement.
Opposition to the international index pricing of the industry has been shared by many Republicans in Congress, who say they feel they adopt drug prices from countries where prices are set by the government, they are in effect socialism. Are importing.
In an interview last month, the Republican strategist, Joel White, called it a “really bad policy” because of “other countries ‘price controls,” and “misguided” imports as it gave into doctors’ offices or hospitals Was targeted on drugs known. .
Sunday’s instructions emerged from Mr Trump’s announcement of four executive orders aimed at lowering drug prices in various ways at the July signing ceremony. The first three were immediately made public, but before they would have any impact on drug prices, the Department of Health and Human Services needed to begin a lengthy rulemaking process.
At the time, Mr. Trump described the fourth order, which he ultimately issued, then repealed, and on Sunday with an expanded order “grandfather of them all.”
Katie Thomas contributed reporting.